Spectral AI Says DeepView SnapShot Wound Imaging System Achieves UKCA Mark And FDA Class 1 Medical Device Classification
Portfolio Pulse from Benzinga Newsdesk
Spectral AI has announced that its DeepView SnapShot Wound Imaging System has achieved UKCA Mark and FDA Class 1 Medical Device Classification. This could potentially increase the company's market reach and boost sales.
October 19, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Spectral AI's DeepView SnapShot Wound Imaging System has received UKCA Mark and FDA Class 1 Medical Device Classification. This could potentially increase the company's market reach and boost sales.
The news of Spectral AI's DeepView SnapShot Wound Imaging System receiving UKCA Mark and FDA Class 1 Medical Device Classification is directly relevant to MDAI as it could potentially increase the company's market reach and boost sales. This could have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100